Form 8-K - Current report:
SEC Accession No. 0000950170-25-017035
Filing Date
2025-02-10
Accepted
2025-02-10 16:05:08
Documents
13
Period of Report
2025-02-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enta-20250210.htm   iXBRL 8-K 41667
2 EX-99.1 enta-ex99_1.htm EX-99.1 212879
3 GRAPHIC img152620751_0.jpg GRAPHIC 16316
  Complete submission text file 0000950170-25-017035.txt   401685

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT enta-20250210.xsd EX-101.SCH 23878
15 EXTRACTED XBRL INSTANCE DOCUMENT enta-20250210_htm.xml XML 4529
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 25605730
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)